Remove author avery-schumacher
article thumbnail

Podcast: The Legal Battle Over Mifepristone – Diagnosing Health Care

Health Law Advisor

Food and Drug Administration’s authority to approve new drugs—will continue to be debated on appeal. Court of Appeals for the Fifth Circuit, the future of mifepristone—and the U.S.

FDA 52